Investing in Whole Person Health

Tilson, Elizabeth Cuervo; Muse, Amelia; Colville, Kathy; Cole, Alisahah; Koller, Christopher F.

doi:10.18043/ncm.81.3.177

Cited by 5 publications

(4 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Wherever financially possible, they should be incorporated into the patient care team. Integrating the care of HIV/HCV co-infected patients within their medical home illustrates the benefits of a whole health approach to primary care delivery (Tilson et al, 2020). With a whole health approach, disease is not treated in isolation but by taking into account the social, economic, behavioral, biologic, and environmental factors, and patients are empowered to take an active part in their own health and well-being.…”

Section: > > Implications For Practicementioning

confidence: 99%

Qualitative Evaluation of a Program to Integrate Hepatitis C Care Into HIV Care Inclusive of Task Shifting to Nonspecialist Providers

Allison

Desai

Kawasaki

et al. 2023

Health Promotion Practice

View full text Add to dashboard Cite

The treatment and cure of hepatitis C (HCV) in people with HIV is particularly important as progression of their liver disease is quicker compared with those who have HCV monoinfection. Innovative approaches are needed to maximize access to curative HCV treatment. Integration of HCV care into HIV primary care with education and support of nonspecialist providers via telementoring offers a solution to specialist workforce shortages. Using focus group qualitative methodology, health care workers’ perspectives regarding this approach, particularly with the Extension for Community Healthcare Outcomes (ECHO) telementoring model, were obtained and are described. Successful integration of HCV care into HIV primary care has demonstrated benefits to patients, including allowing them to remain in their medical home for care. Factors beyond disease that influence their health and wellbeing must also be considered.

show abstract

Section: > > Implications For Practicementioning

confidence: 99%

Qualitative Evaluation of a Program to Integrate Hepatitis C Care Into HIV Care Inclusive of Task Shifting to Nonspecialist Providers

Allison

Desai

Kawasaki

et al. 2023

Health Promotion Practice

View full text Add to dashboard Cite

show abstract

“…Moreover, the absence of disease does not alone determine the health of individuals, multiple factors including but not limited to the social determinants of health do. This underlies the concept of Whole Person Health (Tilson et al, 2020), which integrates behavioral, physical, and social health to optimize individual health.…”

Section: > > App Launchmentioning

confidence: 99%

Mitigating the HIV and Viral Hepatitis Workforce Crisis Through Development of an HIV/Hepatitis C Coinfection Mobile Application

Allison

Prasanna

Choi

et al. 2023

Health Promotion Practice

View full text Add to dashboard Cite

A decline in the HIV workforce has led to a crisis of insufficient expertise to manage people with HIV (PWH), roughly a quarter of whom are coinfected with hepatitis C. Task shifting to nonspecialist providers can contribute to solving the HIV workforce shortage problem, but nonspecialist providers require sufficient training and support to acquire and retain the necessary knowledge and skills. Digital tools including mobile applications (apps) and telementoring which utilizes telecommunication technology for education and skill acquisition can be used for professional development. Described is the development and dissemination of a mobile app specifically for providers managing HIV/HCV coinfection in the United States. The app, through provider professional development, facilitates access to curative HCV treatment in PWH, encourages integration of HCV care into primary care and contributes to national goals to eliminate HIV and viral hepatitis by 2030.

show abstract

“…16,20,69 The 2016 CDC opioid guideline indicated the use of naloxone for a wide array of patients, and some state-wide standing orders (eg, North Carolina) allow dispensing to virtually anyone who voluntarily requests it if they, or someone they are in a position to assist are at risk of opioid overdose. 74 In addition, abuse of opioids, whether illicit or otherwise, is not the only cause, as an overdose may result from pharmacokinetic or pharmacodynamic drug interactions. 3 These notwithstanding, indication or request for, and offer or possession of naloxone are conflated with illicit drugs and drug abuse (OUD), 17,68 and this may be the cornerstone of the naloxone stigma construct, thus making naloxone stigma an offshoot of OUD stigma.…”

Section: Naloxone Stigma As An Offshoot Of the Stigma Of Opioid Use D...mentioning

confidence: 99%

“…Also, according to the 2016 CDC opioid guideline and some state standing orders, naloxone is recommended for a wide variety of people, among which OUD patients are just 1. 7,74 Therefore, firstly, OUD is not the principal indication for naloxone. According to a recent nationwide insurance claims data, the percentage of patients with opioid dependence, or misuse, who receive naloxone prescriptions is very low (1.5%).…”

Section: To What Extent Is the Attitude Toward Naloxone Affected By T...mentioning

confidence: 99%

Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?

Adeosun

2022

Journal of Pharmacy Practice

View full text Add to dashboard Cite

The United States opioid epidemic is fueled by illicit opioid abuse and prescription opioid misuse and abuse. Consequently, cases of opioid use disorder (OUD, opioid addiction), opioid overdose, and related deaths have increased since the year 2000. Naloxone is an opioid antagonist that rapidly reverses opioid intoxication to prevent death from overdose. It is one of the major risk mitigation strategies recommended in the 2016 Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain. However, despite the exponential increase in dispensing and distribution of naloxone, opioid overdose and related deaths have continued to increase; suggesting that the increased naloxone supply still lags the need. This discordance is attributed at least in part to the negative attitude toward naloxone, which is based on the belief that naloxone is only meant for “addicts” and “abusers” (OUD patients). This negative attitude or so-called naloxone stigma is therefore considered a major barrier for naloxone distribution and consequently, overdose-death prevention efforts. This article presents evidence that challenges common assertions about OUD stigma being the sole and direct driving force behind naloxone stigma, and the purported magnitude of the barrier that naloxone stigma constitutes for naloxone distribution programs among the stakeholders (patients, pharmacists, and prescribers). The case was then made to operationalize and quantify the construct among the stakeholders to determine the extent to which OUD stigma drives naloxone stigma, and the relative impact of naloxone stigma as a barrier for naloxone distribution efforts.

show abstract

Investing in Whole Person Health

Cited by 5 publications

References 0 publications

Qualitative Evaluation of a Program to Integrate Hepatitis C Care Into HIV Care Inclusive of Task Shifting to Nonspecialist Providers

Qualitative Evaluation of a Program to Integrate Hepatitis C Care Into HIV Care Inclusive of Task Shifting to Nonspecialist Providers

Mitigating the HIV and Viral Hepatitis Workforce Crisis Through Development of an HIV/Hepatitis C Coinfection Mobile Application

Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?

Contact Info

Product

Resources

About